Skip to main content

Table 1 Baseline characteristics of participants

From: GCKR common functional polymorphisms are associated with metabolic syndrome and its components: a 10-year retrospective cohort study in Iranian adults

 

Total

rs780094

rs780093

rs1260326

CC (n = 2543)

CT (n = 4169)

TT (n = 1879)

CC (n = 2509)

CT (n = 4180)

TT (n = 1902)

CC (n = 2478)

CT (n = 4174)

TT (n = 1939)

With MetS

50.9%

28.1%

49%

23%*

28.2%

48%

23.8%*

27.4%

49.0%

23.6%*

Without MetS

49.1%

32.5%

47.1%

20.4%*

31.6%

48.2%

20.2%*

31.4%

47.7%

20.9%*

Male

42.6%

30.9%

47.8%

21.2%

30.8%

47.5%

21.6%

30.3%

48.0%

21.8%

Female

57.4%

29.7%

48.0%

22.2%

29.3%

48.4%

22.3%

28.8%

48.5%

22.7%

Smoking never

83%

30.6%

47.9%

21.5%

30.3%

48.0%

21.7%

29.7%

48.4%

21.9%

Ex-smoker and smoker

17%

28.0%

48.9%

23.1%

28.0%

49.0%

23.0%

27.8%

48.2%

23.9%

Age (years)

39 ± 16

39 ± 17

39 ± 16

40 ± 17

39 ± 17

39 ± 16

40 ± 17

39 ± 17

39 ± 16

39.5 ± 16.6

WC (cm)

85 ± 21 (53.3%)a

85 ± 21

85 ± 21

85 ± 22

85 ± 22

85 ± 21

85 ± 22

85 ± 22

85 ± 21

85.4 ± 21.5

HDL-C (mg/dl)

42 ± 14 (69.8%)b

43 ± 14

42 ± 14

42 ± 15

43 ± 14

42 ± 14

42 ± 14

43 ± 14

42 ± 14

42 ± 14

TG (mg/dl)

137 ± 86 (41.8%)c

125 ± 75

139 ± 88

150 ± 91†

126 ± 81

137 ± 84

152 ± 92†

125 ± 74

138 ± 88

151 ± 92†

FBS (mg/dl)

89 ± 25 (22.3%)d

90 ± 26

89 ± 23

88 ± 27

90 ± 27

89 ± 23

89 ± 27

90 ± 27

89.4 ± 23.1

88.8 ± 26.5

SBP (mmHg)

110 ± 26(28.8%)e

110 ± 26

110 ± 25

111 ± 27

110 ± 26

110 ± 25

111 ± 26

110 ± 26

110 ± 26

111.1 ± 26

DBP (mmHg)

73 ± 17 (28.8%)e

72 ± 17

73 ± 17

73 ± 18

72 ± 18

73 ± 17

73 ± 18

72 ± 18

72 ± 17

73 ± 17

  1. From the 6th row onwards, data are presented as mean ± SD
  2. aFrequency of subjects with high waist circumference: waist circumference ≥ 90 cm for both genders
  3. bFrequency of subjects low HDL-C: HDL-C < 40 mg/dl in men and < 50 mg/dl in women and drug treatment
  4. cFrequency of subjects high TG: TG ≥ 150 mg/dl and drug treatment
  5. dFrequency of subjects high FBS: FBS ≥ 100 mg/dl and drug treatment
  6. eFrequency of subjects high blood pressure: SBP ≥ 130 mmHg and DBP ≥ 85 mmHg and drug treatment
  7. *Frequency differences of genotypes between MetS and without MetS, P < 0.05
  8. †TT vs. CC, P < 0.05 and TT vs CT, P < 0.05